ADHD Trial, Recruiting (NCT06847165)

ADHD Trial, Recruiting NCT06847165 Sponsor: University of California, Los Angeles Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT06847165 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your child has been diagnosed with Fetal Alcohol Syndrome, Partial Fetal Alcohol Syndrome, or Alcohol-Related Neurodevelopmental Disorder, meaning their mother drank alcohol during pregnancy (certain facial features are not required for this diagnosis)
The mother drank more than 6 drinks per week for at least 2 weeks, and/or had 3 or more drinks on at least 2 occasions during pregnancy
Your child has been diagnosed with ADHD, including difficulties with attention, hyperactivity, impulsivity, and/or planning and organisation
Both the parent and child are able to complete assessments in English
Your child is able to cooperate during an MRI scan (a type of brain imaging)
Your child has an IQ score above 70, measured by a specific intelligence test
Your child is able to follow the study procedures and requirements
Your child is between 8 and 12 years old

Who may not be able to join:

Your child was exposed to other harmful substances during pregnancy that had a greater impact than alcohol (confirm with trial site)
Your child has a known genetic condition linked to ADHD-like symptoms, such as Fragile X syndrome, tuberous sclerosis, or generalised resistance to thyroid hormone
Your child has a serious medical or neurological condition that could affect brain function, such as epilepsy/seizures or a significant head injury
Your child was born before 34 weeks of pregnancy (premature birth)
Your child has metal implants in their body, experiences claustrophobia, wears an insulin pump, or has any other reason they cannot safely have an MRI scan
Your child has been diagnosed with autism spectrum disorder, a psychotic disorder, or a major mood disorder
Your child is currently experiencing thoughts of suicide or has a history of suicide attempts, based on a specific clinical assessment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joseph O'Neill, PhD, UCLA Division of Child & Adolescent Psychiatry

Phone: (310) 267-2710

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06847165

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: (310) 267-2710

More information: https://clinicaltrials.gov/study/NCT06847165

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your child has been diagnosed with Fetal Alcohol Syndrome, Partial Fetal Alcohol Syndrome, or Alcohol-Related Neurodevelopmental Disorder, meaning their mother drank alcohol during pregnancy (certain facial features are not required for this diagnosis)
The mother drank more than 6 drinks per week for at least 2 weeks, and/or had 3 or more drinks on at least 2 occasions during pregnancy
Your child has been diagnosed with ADHD, including difficulties with attention, hyperactivity, impulsivity, and/or planning and organisation
Both the parent and child are able to complete assessments in English
Your child is able to cooperate during an MRI scan (a type of brain imaging)
Your child has an IQ score above 70, measured by a specific intelligence test
Your child is able to follow the study procedures and requirements
Your child is between 8 and 12 years old

Who may not be able to join:

Your child was exposed to other harmful substances during pregnancy that had a greater impact than alcohol (confirm with trial site)
Your child has a known genetic condition linked to ADHD-like symptoms, such as Fragile X syndrome, tuberous sclerosis, or generalised resistance to thyroid hormone
Your child has a serious medical or neurological condition that could affect brain function, such as epilepsy/seizures or a significant head injury
Your child was born before 34 weeks of pregnancy (premature birth)
Your child has metal implants in their body, experiences claustrophobia, wears an insulin pump, or has any other reason they cannot safely have an MRI scan
Your child has been diagnosed with autism spectrum disorder, a psychotic disorder, or a major mood disorder
Your child is currently experiencing thoughts of suicide or has a history of suicide attempts, based on a specific clinical assessment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

26 April 2025

Est. completion

30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Attention Deficit Hyperactivity Disorder (ADHD) Rating Scale Total Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov